Literature DB >> 18159134

Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15.

Su-Ryang Kim1, Yoshiro Saito, Kimie Sai, Kouichi Kurose, Keiko Maekawa, Nahoko Kaniwa, Shogo Ozawa, Naoyuki Kamatani, Kuniaki Shirao, Noboru Yamamoto, Tetsuya Hamaguchi, Hideo Kunitoh, Yuichiro Ohe, Yasuhide Yamada, Tomohide Tamura, Teruhiko Yoshida, Hironobu Minami, Atsushi Ohtsu, Nagahiro Saijo, Jun-ichi Sawada.   

Abstract

A liver-specific transporter organic anion transporting polypeptide 1B1 (OATP1B1, also known as OATP-C) is encoded by SLCO1B1 and mediates uptake of various endogenous and exogenous compounds from blood into hepatocytes. In this study, 15 SLCO1B1 exons (including non-coding exon 1) and their flanking introns were comprehensively screened for genetic variations in 177 Japanese subjects. Sixty-two genetic variations, including 28 novel ones, were found: 7 in the 5'-flanking region, 1 in the 5'-untranslated region (UTR), 13 in the coding exons (9 nonsynonymous and 4 synonymous variations), 5 in the 3'-UTR, and 36 in the introns. Five novel nonsynonymous variations, 311T>A (Met104Lys), 509T>C (Met170Thr), 601A>G (Lys201Glu), 1553C>T (Ser518Leu), and 1738C>T (Arg580Stop), were found as heterozygotes. The allele frequencies were 0.008 for 1738C>T (Arg580Stop) and 0.003 for the four other variations. Arg580Stop having a stop codon at codon 580 results in loss of half of transmembrane domain (TMD) 11, TMD12, and a cytoplasmic tail, which might affect transport activity. In addition, novel variations, IVS12-1G>T at the splice acceptor site and -3A>C in the Kozak motif, were detected at 0.003 and 0.014 frequencies, respectively. Haplotype analysis using -11187G>A, -3A>C, IVS12-1G>T and 9 nonsynonymous variations revealed that the haplotype frequencies for (*)1b, (*)5, (*)15, and (*)17 were 0.469, 0.000 (not detected), 0.037, and 0.133, respectively. These data would provide fundamental and useful information for pharmacogenetic studies on OATP1B1-transported drugs in Japanese.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18159134     DOI: 10.2133/dmpk.22.456

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  12 in total

Review 1.  Uptake carriers and oncology drug safety.

Authors:  Jason A Sprowl; Alex Sparreboom
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

Review 2.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

3.  OATP1B1 polymorphism as a determinant of erythromycin disposition.

Authors:  C S Lancaster; G H Bruun; C J Peer; T S Mikkelsen; T J Corydon; A A Gibson; S Hu; S J Orwick; R H J Mathijssen; W D Figg; S D Baker; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2012-09-19       Impact factor: 6.875

Review 4.  Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Authors:  Gaia Chiara Mannino; Giorgio Sesti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

5.  Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.

Authors:  Anne-Joy M de Graan; Cynthia S Lancaster; Amanda Obaidat; Bruno Hagenbuch; Laure Elens; Lena E Friberg; Peter de Bruijn; Shuiying Hu; Alice A Gibson; Gitte H Bruun; Thomas J Corydon; Torben S Mikkelsen; Aisha L Walker; Guoqing Du; Walter J Loos; Ron H N van Schaik; Sharyn D Baker; Ron H J Mathijssen; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2012-06-18       Impact factor: 12.531

6.  Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.

Authors:  Evita van de Steeg; Viktor Stránecký; Hana Hartmannová; Lenka Nosková; Martin Hřebíček; Els Wagenaar; Anita van Esch; Dirk R de Waart; Ronald P J Oude Elferink; Kathryn E Kenworthy; Eva Sticová; Mohammad al-Edreesi; A S Knisely; Stanislav Kmoch; Milan Jirsa; Alfred H Schinkel
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

Review 7.  Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.

Authors:  Zahra Talebi; Alex Sparreboom; Susan I Colace
Journal:  Methods Mol Biol       Date:  2022

8.  Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.

Authors:  Federico Innocenti; Deanna L Kroetz; Erin Schuetz; M Eileen Dolan; Jacqueline Ramírez; Mary Relling; Peixian Chen; Soma Das; Gary L Rosner; Mark J Ratain
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

9.  Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure.

Authors:  Ayako Tsuboya; Yutaro Kubota; Hiroo Ishida; Ryotaro Ohkuma; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Takuya Tsunoda; Yasutsuna Sasaki; Natsumi Matsumoto; Yusuke Kondo; Yukana Tomoda; Hiroyuki Kusuhara; Ken-Ichi Fujita
Journal:  Cancer Chemother Pharmacol       Date:  2021-06-11       Impact factor: 3.333

10.  Genotyping of OATP2 Variants in a Group of Malaysian Neonates Using High-Resolution Melting Analysis.

Authors:  Fei Liang Wong; Nem Yun Boo; Ainoon Othman
Journal:  Biores Open Access       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.